Exagen Inc.
XGNNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for XGN. That does not mean none is planned.
Get an email about XGN's next catalysts
Track Exagen (XGN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
XGN Earnings Report
EPS Est: $-0.19 | FQ end Sep/2026 | Call: bmo
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Frequently asked questions
When is Exagen Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Exagen Inc. (XGN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track XGN biotech catalysts?→
Add XGN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Exagen Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.